EDITORIAL: Percutaneous Angioplasty Is an Accepted Intervention for the Treatment of PAD.

Cardiovasc Revasc Med

Tulane Heart and Vascular institute, 1430 Tulane Ave, SL-48, New Orleans, LA, 70112. Electronic address:

Published: January 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.12.004DOI Listing

Publication Analysis

Top Keywords

editorial percutaneous
4
percutaneous angioplasty
4
angioplasty accepted
4
accepted intervention
4
intervention treatment
4
treatment pad
4
editorial
1
angioplasty
1
accepted
1
intervention
1

Similar Publications

Aim: This study aimed to evaluate the technical safety and feasibility of gastrectomy for super-elderly patients ≥85-y-old with gastric cancer and to clarify the risk factors for serious postoperative complications in these patients.

Methods: Between 2017 and 2020, 10,203 patients who underwent distal gastrectomy (DG) and 2580 patients who underwent total gastrectomy (TG) were reviewed from the Japanese National Clinical Database. All possible preoperative factors were used to explore the risk factors for serious postoperative complications in the super-elderly patients with gastric cancer.

View Article and Find Full Text PDF

Advances in minimally invasive treatment of malignant obstructive jaundice.

World J Gastrointest Surg

December 2024

Department of Outpatient, Puer People's Hospital, Puer 665000, Yunnan Province, China.

Malignant obstructive jaundice (MOJ) encompasses a range of diseases stemming from malignant tumors such as cholangiocarcinoma, pancreatic cancer, and primary liver cancer, among others, which cause obstruction in both intra- and extra-hepatic bile ducts. This obstruction may lead to elevated bilirubin levels, hepatic function impairment, and a low rate of successful surgical resection in clinical settings. There are various minimally invasive treatment options for MOJ, including endoscopic biliary drainage, ultrasound-guided procedures, and percutaneous biliary tract puncture drainage.

View Article and Find Full Text PDF

Gender Is Not Predictor for Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Coronary Bifurcation.

Korean Circ J

November 2024

Cardiovascular Center, Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

View Article and Find Full Text PDF

Coronary heart disease and type 2 diabetes mellitus (T2DM) often co-occur, presenting substantial health risks, particularly following acute myocardial infarction (AMI). While percutaneous coronary intervention (PCI) is a prevalent treatment, complications such as microvascular dysfunction may lead to heart failure, necessitating additional therapies. This editorial examines the emerging roles of sacubitril/valsartan and sodium-glucose co-transporter 2 inhibitors in managing post-PCI.

View Article and Find Full Text PDF

Timing the Fix: Navigating the Optimal Approach to Complete Revascularization in Acute Coronary Syndromes.

JACC Cardiovasc Interv

December 2024

Gill Heart & Vascular Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!